Skip to main content

Advertisement

Log in

Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Advanced gastric cancer (AGC) rarely presents with disseminated intravascular coagulation (DIC) at the time of diagnosis before treatment with no current standard chemotherapy (CTx) regimen. However the prognosis is extremely poor without CTx. We investigated the effectiveness of sequential CTx with methotrexate and 5-fluorouracil (MF) in chemotherapy-naive AGC patients with DIC.

Methods

We retrospectively examined AGC patients who received first-line CTx and selected those who were diagnosed with DIC before starting CTx to investigate clinical characteristics and responses.

Results

From July 1999 to January 2007, 1,365 patients with unresectable or recurrent AGC received first-line CTx at the National Cancer Center Hospital in Tokyo, Japan. DIC was diagnosed in 22 (1.6%) patients (16 men and 6 women; median age, 56 years) and the performance status of all the patients was 1/2/3 = 9/10/3. Nineteen patients (86%) had histologically diffuse-type adenocarcinoma and 18 (82%) had bone metastasis. Patients received sequential MF every week until progressive disease was confirmed, with DIC improving in 17 (77%) patients. The median time-to-treatment failure for AGC and overall survival were 98 days [95% confidence interval (CI), range 50–146 days] and 154 days (95% CI, range 126–180 days), respectively. Grade 3 or greater toxicities consisted of neutropenia (4 patients, 18%), anemia (9 patients, 40%), thrombocytopenia (4 patients, 18%), and bilirubinemia (1 patient, 5%).

Conclusions

MF was an effective and well-tolerated regimen for improving DIC in chemotherapy-naive AGC patients with DIC; however, the prognosis of the patients remained poor even with improved DIC parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Advanced Colorectal Cancer Meta-Analysis Project (1994) Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol 12:960–969

    Google Scholar 

  • Al-Mondhiry H (1975) Disseminated intravascular coagulation: experience in a major cancer center. Thromb Diath Haemorrh 34:181–193

    CAS  PubMed  Google Scholar 

  • Cadman E, Heimer R, Davis L (1979) Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science 205:1135–1137

    Article  CAS  PubMed  Google Scholar 

  • Chao Y, Teng HC, Hung HC, King KL, Li CP, Chi KH, Yen SH, Chang FY (2000) Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation. Jpn J Clin Oncol 30:122–125

    Article  CAS  PubMed  Google Scholar 

  • Fernandes DJ, Bertino JR (1980) 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. Proc Natl Acad Sci USA 77:5663–5667

    Article  CAS  PubMed  Google Scholar 

  • Hamaguchi T, Shirao K, Yamamichi N, Hyodo I, Koizumi W, Seki S, Imamura T, Honma H, Ohtsu A, Boku N, Mukai T, Yamamoto S, Fukuda H, Yoshida S (2008) A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial. Jpn J Clin Oncol 38:432–437

    Article  PubMed  Google Scholar 

  • Hironaka SI, Boku N, Ohtsu A, Nagashima F, Sano Y, Muto M, Fujii T, Tajiri H, Yoshida S (2000) Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis. Gastric Cancer 3:19–23

    Article  PubMed  Google Scholar 

  • Huang TC, Yeh KH, Cheng AL, Hsu CH (2008) Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation. Anticancer Res 28:1293–1297

    CAS  PubMed  Google Scholar 

  • Jiang CF, Chen HC, Ng KW, Tan SW, Wu CS, Hsueh SC, Chung MT (1997) Gastric adenocarcinoma with microangiopathic hemolytic anemia and disseminated intravascular coagulation: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 59:204–209

    CAS  Google Scholar 

  • Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin DB, Kim HT, Kim HJ et al (1993) A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 71:3813–3818

    Article  CAS  PubMed  Google Scholar 

  • Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221

    Article  CAS  PubMed  Google Scholar 

  • Konishi T, Hiraishi M, Mafune K, Miyama T, Hirata T, Mori K, Nishina H, Idezuki Y (1994) Therapeutic efficacy and toxicity of sequential methotrexate and 5-fluorouracil in gastric cancer. Anticancer Res 14:1277–1279

    CAS  PubMed  Google Scholar 

  • Konishi T, Noie T, Yoshida J, Mafune K, Makuuchi M (1999) Treatment of peritoneal dissemination of gastric cancer with sequential methotrexate and 5-fluorouracil. Gastric Cancer 2:52–56

    Article  PubMed  Google Scholar 

  • Levi M, Ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586–592

    Article  CAS  PubMed  Google Scholar 

  • Okajima K, Sakamoto Y, Uchiba M (2000) Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol 65:215–222

    Article  CAS  PubMed  Google Scholar 

  • Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori PP, Cavazzini G, Desiderio F, Monti F, Forghieri ME, Ravaioli A (1995) Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology 52:505–508

    Article  CAS  PubMed  Google Scholar 

  • Perez JE, Lacava JA, Dominguez ME, Rodriguez R, Barbieri MR, Ortiz EH, Romero Acuna LA, Langhi MJ, Romero Acuna JM, Vallejo CT, Leone BA, Machiavelli MR, Romero AO (1998) Biochemical modulation of 5-fluorouracil by methotrexate in patients with advanced gastric carcinoma. Am J Clin Oncol 21:452–457

    Article  CAS  PubMed  Google Scholar 

  • Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G (2001) Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 86:828–833

    CAS  PubMed  Google Scholar 

  • Sase T, Wada H, Nishioka J, Abe Y, Gabazza EC, Shiku H, Suzuki K, Nakamura S, Nobori T (2003) Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases. Thromb Haemost 89:660–665

    CAS  PubMed  Google Scholar 

  • Tahara M, Ohtsu A, Boku N, Nagashima F, Muto M, Sano Y, Yoshida M, Mera K, Hironaka S, Tajiri H, Yoshida S (2001) Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study. Gastric Cancer 4:212–218

    Article  CAS  PubMed  Google Scholar 

  • Tokar M, Bobilev D, Ariad S, Geffen DB (2006) Disseminated intravascular coagulation at presentation of advanced gastric cancer. Isr Med Assoc J 8:853–855

    CAS  PubMed  Google Scholar 

  • Tsuchiya Y, Ishibashi H, Ohtsuka T, Nagasawa K, Niho Y, Ide K (1989) Mucin-producing signet ring cell carcinoma of stomach accompanied by microangiopathic hemolytic anemia and disseminated intravascular coagulation: a case report. Fukuoka Igaku Zasshi 80:477–481

    CAS  PubMed  Google Scholar 

  • Yamao T, Shimada Y, Shirao K, Ohtsu A, Ikeda N, Hyodo I, Saito H, Iwase H, Tsuji Y, Tamura T, Yamamoto S, Yoshida S (2004) Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Jpn J Clin Oncol 34:316–322

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

We received no financial support for this study and report no conflicts of interest. Informed consent was obtained from all patients before initiating chemotherapy. This study was approved by the president of National Cancer Center Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuniaki Shirao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takashima, A., Shirao, K., Hirashima, Y. et al. Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis. J Cancer Res Clin Oncol 136, 243–248 (2010). https://doi.org/10.1007/s00432-009-0655-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0655-8

Keywords

Navigation